https://www.selleckchem.com/pr....oducts/epacadostat-i
6 ± 8.4, 0.0001) compared with their preoperative scores and remained at the same level from 3 to 12 months postoperatively, whereas those in Group B became significantly worse (32.0 ± 7.8, 0.0001) than their preoperative ones. There were no differences between AMS scores in Groups A and B at every postoperative period ( = 0.3259, 0.2730, 0.2429, 0.4629, 0.1771 at 1, 3, 6, 9, and 12 months after surgery, respectively). Our results indicate that AMSs in PCa patients with the LOH syndrome can expect the same le
Like
Comment
Share
